Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1091]
News [2718]
Articles [182]
Editorials [9]
Conferences [110]
elearning [25]
Combination of targeted therapies could help overcome treatment resistance in advanced prostate cancer
Combination of targeted therapies could help overcome treatment resistance in advanced prostate cancer
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery
Experimental immunotherapy may help patients with high-risk bladder cancer avoid bladder removal surgery
Casdatifan demonstrates durable tumour responses in heavily pretreated patients with advanced kidney cancer, study shows
Casdatifan demonstrates durable tumour responses in heavily pretreated patients with advanced kidney cancer, study...
New mechanoresistant cancer cells show how they survive high stress environments
New mechanoresistant cancer cells show how they survive high stress environments
Study reveals how networks of switches in DNA, which regulate gene expression, drive cancer growth
Study reveals how networks of switches in DNA, which regulate gene expression, drive cancer growth
DNA blood test improves patient selection for radiopharmaceutical therapy in prostate cancer
DNA blood test improves patient selection for radiopharmaceutical therapy in prostate cancer
Fasting primes gut microbiome to improve intestinal recovery after radiation treatment
Fasting primes gut microbiome to improve intestinal recovery after radiation treatment
Genome editing in rats enables more accurate ER+ breast cancer models
Genome editing in rats enables more accurate ER+ breast cancer models
Researchers discover new form of hereditary prostate cancer
Researchers discover new form of hereditary prostate cancer
FDA approves pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph each with enfortumab vedotin-ejfv for muscle invasive bladder cancer
FDA approves pembrolizumab or pembrolizumab and berahyaluronidase alfa-pmph each with enfortumab vedotin-ejfv for...

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation